Copyright
©The Author(s) 2020.
World J Clin Cases. Jul 26, 2020; 8(14): 2988-2999
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2988
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2988
Table 1 Summary of patient characteristics in the older and younger groups
Parameter | Overall (n = 614) | Age ≥ 80 (n = 146) | Age < 80 (n = 468) | P value | |
Age [median (IQR)] (yr) | 68 (54-79) | 83 (81-86) | 62 (50-71) | ||
Charlson score [median (IQR)] | 0 (0-1) | 1 (0-2) | 0 (0-1) | 0.001a | |
Charlson score ≥ 2 | 21% (129) | 29.5% (43) | 18.4% (86) | 0.005b | |
ERCP procedure time [median (IQR)] (min) | 30 (23-45) | 30 (23-45) | 30 (24-45) | 0.711a | |
Cannulation time [median (IQR)] (min) | 3.6 (0.8-11.8) | 3.4 (0.8-11.2) | 3.7 (0.8-12) | 0.292a | |
Male | 53.2% (327) | 51.4% (75) | 53.8% (252) | 0.636b | |
Cannulation success rate | 96.7% (595) | 96.6% (141) | 96.8% (454) | 0.547b | |
Indications | |||||
Biliary stones | 82.4% (506) | 82.9% (121) | 82.3% (385) | 0.468b | |
Benign strictures | 12.7% (78) | 11% (16) | 13.2% (62) | 0.287b | |
Cholangiocarcinoma | 4.2% (26) | 4.8% (7) | 4.1% (19) | 0.424b | |
Cholangitis | 9.1% (56) | 6.8% (10) | 9.8% (46) | 0.180b | |
Biliary pancreatitis | 5.9% (36) | 4.8% (7) | 6.2% (29) | 0.346b | |
Chronic pancreatitis | 1.3% (8) | 0% (0) | 1.7% (8) | 0.113b | |
Ampullary carcinoma | 3.3% (20) | 5.5% (8) | 2.6% (12) | 0.076b | |
Pancreatic cancer | 3.6% (22) | 2.7% (4) | 3.8% (18) | 0.371b | |
Comorbidities | |||||
Hypertension | 29.5% (181) | 38.4% (56) | 26.7% (125) | 0.009b | |
Cardiac diseases | 7.5% (46) | 15.1% (22) | 5.1% (24) | < 0.001b | |
Diabetes mellitus | 11.7% (72) | 13% (19) | 11.3% (53) | 0.558b | |
Neurological diseases | 12.5% (77) | 21.9% (32) | 9.6% (45) | < 0.001b | |
Hepatic diseases | 7.8% (48) | 5.5% (8) | 8.5% (40) | 0.290b | |
Malignancy | 9.3% (57) | 11% (16) | 8.8% (41) | 0.256b | |
Others | 9.9% (61) | 14.4% (21) | 8.5% (40) | 0.031b | |
Periampullary diverticulum | 19.7% (121) | 29.5% (43) | 16.7% (78) | 0.001b | |
Cannulation grade of difficulty | |||||
Easy cannulation | 66% (405) | 67.1% (98) | 65.6% (307) | 0.621b | |
Moderate cannulation | 11.7% (72) | 10.3% (15) | 12.2% (57) | 0.658b | |
Difficult cannulation | 22.3% (137) | 22.6% (33) | 22.2% (104) | 0.910b | |
Second ERCP | 20.4% (125) | 20.5% (30) | 20.3% (95) | 0.512b | |
Adverse events | 9.8% (60) | 13% (19) | 8.8% (41) | 0.089b | |
PEP | 5.2% (32) | 2.7% (4) | 6% (28) | 0.088b | |
Perforation | 0.5% (3) | 0.7% (1) | 0.4% (2) | 0.557b | |
Bleeding | 1.9% (12) | 4.1% (6) | 1.3% (6) | 0.111b | |
Cholangitis | 0.6% (4) | 0.7% (1) | 0.6% (3) | 0.663b | |
Cardiopulmonary | 0.6% (4) | 0.7% (1) | 0.6% (3) | 0.443b | |
Duration of hospitalization [median (IQR)] (d) | 9 (6-13) | 9 (7-13) | 9 (6-13) | 0.208a | |
Pancreatic stent | 10.4% (64) | 7.5% (11) | 11.3% (53) | 0.124b | |
Anti-thrombotic drug | 5.5% (34) | 7.5% (11) | 4.9% (23) | < 0.001b |
- Citation: Tabak F, Wang HS, Li QP, Ge XX, Wang F, Ji GZ, Miao L. Endoscopic retrograde cholangiopancreatography in elderly patients: Difficult cannulation and adverse events. World J Clin Cases 2020; 8(14): 2988-2999
- URL: https://www.wjgnet.com/2307-8960/full/v8/i14/2988.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i14.2988